This inventor holds 4 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Agency for Science, Technology and Research, Singapore Health Services Pte Ltd. Active years: 2016-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 1,561 
4 out of 140 
Years Active: 2016-2019
Title: Innovator Kok Hian Tan: Pioneering Advancements in Medical Diagnostics
Introduction
Kok Hian Tan is a distinguished inventor based in Singapore, SG, renowned for his contributions to the field of medical diagnostics. With a notable portfolio of four patents, he has made significant strides in understanding and monitoring cellular states, particularly in relation to pre-eclampsia. His innovative approaches have the potential to greatly influence patient care and diagnostics.
Latest Patents
Among his latest patents, Kok Hian Tan has developed a method for microparticle fractionation. This method involves monitoring the state of cells, tissues, organs, or organisms by establishing a ratio of selected polypeptides within microparticles. Specifically, it compares polypeptides associated with GM1 gangliosides, which bind to Cholera Toxin B (CTB), against those related to exposed phosphatidylserine binding to Annexin V. The established ratio serves as an indicator of the health state of the biological sample.
Additionally, Tan has patented a method for detecting pre-eclampsia through the analysis of biomarkers. This involves measuring the expression, activity, or quantity of specific biomarker polypeptides, such as PlGF, FLT1, and IL6, in microparticles from affected cells. By comparing these levels to those in unaffected samples, clinicians can gain valuable insights into pre-eclampsia conditions.
Career Highlights
Throughout his career, Kok Hian Tan has been associated with notable organizations, including Singapore Health Services Pte Ltd and the Agency for Science, Technology and Research (A*STAR). His work in these institutions has enabled him to apply his innovative ideas effectively in real-world scenarios.
Collaborations
Kok Hian Tan has also collaborated with esteemed colleagues in his field, including Sai Kiang Lim. These partnerships have likely facilitated the exchange of ideas and fostered the development of groundbreaking projects, further enhancing the impact of their research in medical diagnostics.
Conclusion
Kok Hian Tan's contributions to medical innovations, particularly in the detection of pre-eclampsia and cellular monitoring, showcase his commitment to advancing healthcare solutions. With his ongoing efforts in research and invention, he continues to play a vital role in the evolution of medical diagnostics and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile